The Regulation of Gene Expression via Epigenetic Mechanisms during Onset of Obesity, Type 2 Diabetes
The Regulation of Gene Expression via Epigenetic Mechanisms during Onset of Obesity, Type 2 Diabetes
批准号:
8999852
负责人:
Yi Li
金额:
$9.57万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-05 至 2020-03-31
关键词:
3T3-L1 CellsAcidsAddressAdipocytesAdipose tissueAdultAffectAreaBiomedical ResearchCell DeathCellsCessation of lifeChildChronicComplexDNA MethylationDNA Microarray ChipDataDevelopmentDietDiseaseDrug TargetingEnvironmental Risk FactorEpigenetic ProcessEvolutionFatty AcidsGene ExpressionGene Expression RegulationGenesGeneticGenetic CodeGenomic DNAHealthHispanic Graduate StudentHispanicsHumanHuman GenomeHyperlipidemiaIndividualInfiltrationInsulin ResistanceLeadLife StyleLinoleic AcidsLipidsMediatingMethylationMicroRNAsModificationMusMuscleMuscle CellsNon-Insulin-Dependent Diabetes MellitusObesityPalmitic AcidsPatientsPlayPolyunsaturated Fatty AcidsRegulationResearchResearch Project GrantsRoleSaturated Fatty AcidsSmall Interfering RNAStagingStudentsTechniquesTimeTissuesUnderrepresented StudentsUnsaturated Fatty Acidsadipocyte differentiationepigenetic regulationexperiencepublic health relevancetargeted treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): During the last a few decades, obesity and obesity related type 2 diabetes have become serious health problems worldwide. Obesity among both adults and children has significantly increased since 1990. During such a short period of time, genetic coding of human beings cannot be changed so significantly by evolution. Studies in chronic complex disorders such as obesity/type 2 diabetes are shifting the emphasis from genetic causative factors to epigenetic and environmental effects. Environmental factors including diets and lifestyles may play an important role in development of obesity/type 2 diabetes by influencing the epigenetic modifications to the human genome. It has been demonstrated recently that circulating fatty acids are associated with adiposity, insulin resistance, and muscle cell death. Now, the key question is what actual factors in adipocytes and muscle cells induced by fatty acids are mediating adiposity, insulin resistance, and muscle cell death. It is very likely each of the problems may be a result of regulation of more than one gene by fatty acids. Our preliminary data indicated that both saturated fatty acids and polyunsaturated fatty acids induced lipid accumulation in differentiated adipocytes while saturated fatty acids differentially affected adipocytes and muscles cells. The proposed project systematically addresses these questions using both adipocytes and muscle cells from the aspect of epigenetics. Aim 1 will identify the genes that are essential for lipid accumulation and insulin resistance in adipocytes. The genes that are essential for lipid accumulation should be the genes that are regulated by saturated fatty acids and unsaturated fatty acids in the same manner since both types of fatty acids cause significant lipid accumulation in differentiated adipocytes. The genes that are related with insulin resistance in differentiated adipocytes should be regulated by saturated fatty acids and polyunsaturated fatty acids in opposite manners since the two types of fatty acids have different effects on insulin resistance in differentiated adipocytes. Aim 2 will identify the genes essential for mediating cell death and insulin resistance
in muscle cells. The genes that are mediating muscle cell death and insulin resistance should be regulated by saturated fatty acids and polyunsaturated fatty acids in opposite manners in muscle cells since these two types of fatty acids have different effects on muscle cell death and insulin resistance in muscle cells according to our preliminary data. Aim 3 will determine if epigenetic modifications are involved in mediating expression of genes identified in Aim 1&2. Studies in this Aim will be mainly focused on methylation and microRNAs. This project may directly lead to identification of potential drug targets. This project will also provide opportuniies for 2 graduate and 10 undergraduate Hispanic students to experience biomedical research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lactation on Breast Tumorigenesis
-
批准号:10668820
-
项目类别:
-
资助金额:$55.33万
-
财政年份:2023
-
负责人:Yi Li
-
依托单位:
Mutating E-cadherin in rats to model lobular breast cancer
-
批准号:10830164
-
项目类别:
-
资助金额:$17.46万
-
财政年份:2022
-
负责人:Yi Li
-
依托单位:
Next Generation Rat Models of ER+ Breast Cancer
-
批准号:10591512
-
项目类别:
-
资助金额:$58.52万
-
财政年份:2022
-
负责人:Yi Li
-
依托单位:
Next Generation Rat Models of ER+ Breast Cancer
-
批准号:10464834
-
项目类别:
-
资助金额:$61.22万
-
财政年份:2022
-
负责人:Yi Li
-
依托单位:
New Statistical Methods for Modelling Cancer Outcomes
-
批准号:10542801
-
项目类别:
-
资助金额:$33.61万
-
财政年份:2021
-
负责人:Yi Li
-
依托单位:
New Statistical Methods for Modelling Cancer Outcomes
-
批准号:10317123
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2021
-
负责人:Yi Li
-
依托单位:
CSF Clearance in Sporadic Alzheimer's Disease
-
批准号:10606516
-
项目类别:
-
资助金额:$75.94万
-
财政年份:2019
-
负责人:Yi Li
-
依托单位:
CSF Clearance in Sporadic Alzheimer's Disease
-
批准号:9981182
-
项目类别:
-
资助金额:$82.77万
-
财政年份:2019
-
负责人:Yi Li
-
依托单位:
CSF Clearance in Sporadic Alzheimer's Disease
-
批准号:9993210
-
项目类别:
-
资助金额:$80.98万
-
财政年份:2019
-
负责人:Yi Li
-
依托单位:
CSF Clearance in Sporadic Alzheimer's Disease
-
批准号:10390277
-
项目类别:
-
资助金额:$77.94万
-
财政年份:2019
-
负责人:Yi Li
-
依托单位:
The Regulation of Gene Expression via Epigenetic Mechanisms during Onset of Obesity, Type 2 Diabetes
-
批准号:9270051
-
项目类别:
-
资助金额:$10.32万
-
财政年份:2016
-
负责人:Yi Li
-
依托单位:
The cell of origin of breast cancer metastasis
-
批准号:9188064
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2015
-
负责人:Yi Li
-
依托单位:
Integrated Analysis of High Throughput Cancer Genomic Data
-
批准号:8401160
-
项目类别:
-
资助金额:$11.63万
-
财政年份:2011
-
负责人:Yi Li
-
依托单位:
Integrated Analysis of High Throughput Cancer Genomic Data
-
批准号:8117960
-
项目类别:
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:Yi Li
-
依托单位:
Integrated Analysis of High Throughput Cancer Genomic Data
-
批准号:8369374
-
项目类别:
-
资助金额:$20.2万
-
财政年份:2011
-
负责人:Yi Li
-
依托单位:
Oncogene susceptibility: physiological state & breast cell differentiation
-
批准号:8208111
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2010
-
负责人:Yi Li
-
依托单位:
Oncogene susceptibility: physiological state & breast cell differentiation
-
批准号:8606424
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2010
-
负责人:Yi Li
-
依托单位:
Oncogene susceptibility: physiological state & breast cell differentiation
-
批准号:8444583
-
项目类别:
-
资助金额:$29.04万
-
财政年份:2010
-
负责人:Yi Li
-
依托单位:
Oncogene susceptibility: physiological state & breast cell differentiation
-
批准号:8045518
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2010
-
负责人:Yi Li
-
依托单位:
Oncogene susceptibility: physiological state & breast cell differentiation
-
批准号:7889225
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2010
-
负责人:Yi Li
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: